Tailoring N-Glycan Biosynthesis for Production of Therapeutic Proteins in Saccharomyces cerevisiae

Research output: Contribution to journalArticleScientificpeer-review


Research units


The ability to control and adjust the N-glycosylation pathway of Saccharomyces cerevisiae is a key step toward production of therapeutic glycoproteins such as antibodies or erythropoietin. The focus of this chapter is to describe the road from yeast-type N-glycosylation to human-type complex N-glycosylation. The chapter describes the cell engineering and provides the detailed analytical procedures required to perform glycan analysis using MALDI-TOF mass spectrometry.


Original languageEnglish
Pages (from-to)227-241
Number of pages15
JournalMethods in molecular biology (Clifton, N.J.)
Publication statusPublished - 1 Jan 2019
MoE publication typeA1 Journal article-refereed

    Research areas

  • Glycan analysis, Glycoengineering, Glycosylation efficiency, Glycosyltransferases, MALDI-TOF MS, S. cerevisiae

ID: 32207204